CPS Technologies (CPSH) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
11 May, 2026Executive summary
Q1 2026 revenue was $7.0 million, down from $7.5 million year-over-year, mainly due to order timing and reduced demand from a major customer, but future growth is expected and fundamentals remain strong.
Gross margin declined to 8.6%–9% from 16%–16.4% in Q1 2025, impacted by lower sales, inventory build, gold pricing, and increased R&D spending.
Operating loss was $500,000–$523,000 versus an operating profit of $100,000–$130,000 in Q1 2025; net loss was $294,000–$300,000 or $(0.02) per share, compared to net income of $96,000–$100,000 or $0.01 per share a year ago.
Leadership transition is underway, with Chris Fraser set to become CFO in May 2026, succeeding Chuck Griffith.
Inflation, supply chain risks, and customer concentration are present, but most cost increases have been passed to customers so far.
Financial highlights
Product sales were $7,028,748 in Q1 2026 vs. $7,505,921 in Q1 2025.
Gross profit was $606,878 in Q1 2026 vs. $1,231,001 in Q1 2025.
SG&A expenses were approximately $1.1 million, up 3% year-over-year.
Cash and marketable securities totaled $12.5 million at quarter-end, with cash and cash equivalents at $5.7 million and marketable securities at $6.8 million.
Inventory increased to $7.1 million from $5.6 million, supporting continued shipments and the facility move.
Outlook and guidance
Management expects continued revenue growth and margin improvement as inventory levels normalize and product mix changes.
The company is finalizing plans to move to a larger, advanced manufacturing facility later in 2026.
Operations are expected to be funded for the remainder of 2026 from operations and existing cash balances.
The SBIR and STTR programs have been reauthorized through 2031, providing long-term funding clarity.
Elevated uncertainty remains due to inflation, tariffs, and customer concentration.
Latest events from CPS Technologies
- 2026 meeting seeks approval for directors, executive pay, share increase, and auditor ratification.CPSH
Proxy filing20 Mar 2026 - Annual meeting to vote on directors, executive pay, share increase, and auditor ratification.CPSH
Proxy Filing10 Mar 2026 - Record revenue, margin gains, and facility expansion drive strong growth outlook.CPSH
Q4 20253 Mar 2026 - Revenue and margins fell in Q2, but new contracts and product launches support future growth.CPSH
Q2 20242 Feb 2026 - Record Q2 2025 revenue, profitability, and strong demand drive a positive outlook.CPSH
Q2 202529 Jan 2026 - Record revenue, margin gains, and a $9.5M raise drive expansion and strong growth outlook.CPSH
Q3 202529 Jan 2026 - Record Q1 2025 revenue and profitability, with strong growth and improved margins.CPSH
Q1 202529 Jan 2026 - Q3 revenue fell 32% to $4.2M, but new contracts and capacity boost outlook for 2025.CPSH
Q3 202429 Jan 2026 - Record revenue, $12M order, and new contracts drive growth and innovation outlook.CPSH
21st Virtual Investor Summit Microcap Event12 Jan 2026